Orphanin FQ or nociceptin (OFQ/N), the heptadecapeptide agonist for the NOP receptor, is derived by proteolytic processing from a precursor protein, preproOFQ/N. Previous studies have reported alternative splicing between exons 3 and 4 of the mouse OFQ/N transcript, which, upon translation, would yield precursor proteins with different C-termini. Using RT-PCR, we identi®ed similar alternative splicing of preproOFQ/N transcripts in humans and rats. In addition, we identi®ed two novel human preproOFQ/N splice variants from which exon 2 has been excised and which also undergo alternative splicing between exons 3 and 4. Exon 2 contains the translational start site for preproOFQ/N and encodes the signal peptide sequence. In vitro translation of cRNAs lacking exon 2 yields shorter translation products which arise from an alternative initiator methionine located within exon 3. The resulting proteins would lack a signal peptide sequence, which would likely alter their cellular traf®cking and processing. Orphanin FQ (OFQ) or nociceptin (N), a 17 amino acid peptide, has been isolated independently by two groups and shown to bind and activate the NOP receptor, also known as the ORL1 receptor (Meunier et al. 1995; Reinscheid et al. 1995) . The NOP receptor is a seven transmembrane G protein-coupled receptor which has < 60% amino acid identity to the classical opioid receptors (mu, delta and kappa) (Mollereau et al. 1994) . Similar to the opiate system, OFQ/N binding to the NOP receptor activates pertussis toxin-sensitive Gi/o proteins, which can inhibit adenyl cyclase (Meunier et al. 1995; Reinscheid et al. 1995) , inhibit voltage-gated calcium currents (Connor et al. 1996) , induce potassium currents (Matthes et al. 1996) and activate the MAP kinase pathway (Hawes et al. 1998). However, unlike the opiate system, pharmacological studies have revealed a complex role for OFQ/N in the regulation of analgesia. Factors such as the route of peptide administration, dosage, strain of animals, behavioral state of the animals and the types of behavioral tests used have been shown to affect whether OFQ/N elicits analgesia or hyperalgesia (reviewed by Zaki 1998; Harrison and Grandy 2000). In addition to effects on pain perception, treatment with OFQ/N has also been shown to modulate locomotion, autonomic output, memory and states of anxiety in response to acute stressors (reviewed by Harrison and Grandy, 2000; Zaki 1998) . OFQ/N is derived from a longer precursor protein, preproOFQ/N (ppOFQ/N), which encodes other putative bioactive peptides (Meunier et al. 1995; Nothacker et al. 1996; Pan et al. 1996; Okuda-Ashitaka et al. 1998; Rossi et al. 1998) . Immediately preceding OFQ/N, and¯anked by dibasic residues, a peptide named nocistatin (Nct) has been isolated from rat, mouse and human CNS (Lee et al. 1999) . When administered intrathecally, Nct is effective at inhibiting OFQ/N-induced hyperalgesia (Okuda-Ashitaka et al. 1998; Yamamoto and Sakashita 1999) , inhibiting OFQ/N-induced glutamate release from rat cerebrocortical slices (Nicol et al. 1998) , and blocking OFQ/N-precipitated memory impairment (Hiramatsu and Inoue 1999a, b). The effects of Nct are mediated by, as yet uncharacterized, receptor(s) that appear distinct from the NOP receptor (Okuda-Ashitaka et al. 1998 
Orphanin FQ (OFQ) or nociceptin (N), a 17 amino acid peptide, has been isolated independently by two groups and shown to bind and activate the NOP receptor, also known as the ORL1 receptor (Meunier et al. 1995; Reinscheid et al. 1995) . The NOP receptor is a seven transmembrane G protein-coupled receptor which has < 60% amino acid identity to the classical opioid receptors (mu, delta and kappa) (Mollereau et al. 1994) . Similar to the opiate system, OFQ/N binding to the NOP receptor activates pertussis toxin-sensitive Gi/o proteins, which can inhibit adenyl cyclase (Meunier et al. 1995; Reinscheid et al. 1995) , inhibit voltage-gated calcium currents (Connor et al. 1996) , induce potassium currents (Matthes et al. 1996) and activate the MAP kinase pathway (Hawes et al. 1998) . However, unlike the opiate system, pharmacological studies have revealed a complex role for OFQ/N in the regulation of analgesia. Factors such as the route of peptide administration, dosage, strain of animals, behavioral state of the animals and the types of behavioral tests used have been shown to affect whether OFQ/N elicits analgesia or hyperalgesia (reviewed by Zaki 1998; Harrison and Grandy 2000) . In addition to effects on pain perception, treatment with OFQ/N has also been shown to modulate locomotion, autonomic output, memory and states of anxiety in response to acute stressors (reviewed by Harrison and Grandy, 2000; Zaki 1998) . OFQ/N is derived from a longer precursor protein, preproOFQ/N (ppOFQ/N), which encodes other putative bioactive peptides (Meunier et al. 1995; Nothacker et al. 1996; Pan et al. 1996; Okuda-Ashitaka et al. 1998; Rossi et al. 1998) . Immediately preceding OFQ/N, and¯anked by dibasic residues, a peptide named nocistatin (Nct) has been isolated from rat, mouse and human CNS (Lee et al. 1999) . When administered intrathecally, Nct is effective at inhibiting OFQ/N-induced hyperalgesia (Okuda-Ashitaka et al. 1998; Yamamoto and Sakashita 1999) , inhibiting OFQ/N-induced glutamate release from rat cerebrocortical slices (Nicol et al. 1998) , and blocking OFQ/N-precipitated memory impairment (Hiramatsu and Inoue 1999a, b) . The effects of Nct are mediated by, as yet uncharacterized, receptor(s) that appear distinct from the NOP receptor (Okuda-Ashitaka et al. 1998) . C-Terminal to the OFQ/N peptide in ppOFQ/N, and also¯anked by dibasic amino acids, is a putative heptadecapeptide that is 100% conserved among mice, rats and humans. Named OFQ2, intracerebroventricular injections of this peptide in mice induce dopamine-mediated locomotor activity (Florin et al. 1997) . In addition, either intracerebroventricular or intrathecal administration of OFQ2 in mice has been shown to have antinociceptive properties (Rossi et al. 1998) . The mechanisms mediating these behavioral actions remain to be elucidated. ppOFQ/N is encoded by an < 1.3-kb transcript derived from four exons (Mollereau et al. 1996) . Exon 1 constitutes the majority of the 5 H -UTR. Exon 2 contains the translational start site and the signal peptide, while exon 3 contains the coding region for the multiple bioactive peptides. Exon 4 encodes the 3 H -UTR and polyadenylation signal (Mollereau et al. 1996) . Very recently the promoter region upstream of exon 1 has been characterized and shown to contain a number of regulatory sites including cAMP response elements and glucocorticoid receptor binding sites (Xie et al. 1999) .
Coinciding with the discovery of OFQ/N, Saito and colleagues independently isolated both ppOFQ/N (N23K), as well as an alternative splice variant (N27K), from dibuyryl cAMP-treated mouse neuroblastoma cell line NS20Y (Saito et al. 1995 (Saito et al. , 1996 . The alternatively spliced ppOFQ/N transcript, N27K, results from the excision of 57 bases from the 3 H -end of exon 3. This shorter transcript removes a stop codon in exon 3 and thereby extends the C-terminus of ppOFQ/N by 25 amino acids and into exon 4 (Saito et al. 1996) . This group demonstrated that transfection of NS20Y neuroblastoma cells with either of the alternative splice constructs promotes neurite outgrowth and that cotransfection with both splice products is more ef®cacious than transfection with either alone (Saito et al. 1997) . This suggests that the two proteins may independently affect neuronal differentiation. In addition, processed OFQ/N peptide was shown to be ineffective at promoting this neuronal differentiation, suggesting that the NOP receptor alone does not mediate these effects (Saito et al. 1997) .
Because alternative splicing of the mouse ppOFQ/N transcripts can yield two different precursor proteins, it was of interest to determine whether this splicing pattern is conserved in other species. Here, we used RT-PCR to analyze the spliced products of the rat and human ppOFQ/N transcripts and describe identical alternative use of donor sites in exon 3 of both species. Furthermore, from the human cortex, we identi®ed two novel splice variants of ppOFQ/N that eliminate exon 2 from their transcripts. In vitro translation experiments of these novel transcripts reveal that translation can be initiated from an alternative translational start site located within exon 3, resulting in truncated forms of the precursor proteins devoid of signal peptide sequences.
Materials and methods

RNA preparation
Unless noted otherwise, adult male Sprague2Dawley rats and BALB/c mice were used and tissues of interest dissected and snap frozen on dry ice. Human surgical cortex was similarly frozen and kindly provided by Dr Harry Vinters. Total RNA was extracted using Trizol reagent (Life Technologies, Rockville, MD, USA) according to manufacturer's recommendations. mRNA from adult rat brain was isolated using the Poly(A)Tract kit (Promega, Madison, WI, USA). RNA integrity was assessed by agarose gel electrophoresis and concentration assessed spectrophotomentrically. Developmental Sprague2Dawley rat brain mRNA samples and human fetal brainstem total RNA samples were generously provided by Drs Jim Boulter and Thomas Prybil, respectively.
Reverse transcription PCR First-strand cDNA synthesis was performed using either 2 mg of total RNA or 300 ng of poly(A 1 ) RNA with Superscript II (Life Technologies) in the recommended buffers and either 150 ng of random hexamers or 50 ng of oligo(dT), respectively. One-tenth of the RT reactions were used in each of the subsequent ampli®cation reactions using the primer pairs listed in Table 1 . All primers were synthesized by Gibco-BRL (Life Technologies). ppOFQ/N primers were based on the rat and human published sequences (Accession nos U48262and U48263, respectively), whereas the b-actin primers were selected according to Raff et al. (1997) . The ®nal ampli®-cation conditions were as follows: 20±25 pmoles of each primer, 2.5 mm MgCl 2 , 200 mm dNTP and 2.5 units of Hot Start Taq Polymerase (Qiagen, Valencia, CA, USA). Ampli®cation for all tissues was carried out in a GeneAmp 2400 cycler (Perkin-Elmer, Foster City, CA, USA) and performed following an initial denaturation step of 15 min at 948C. For rat tissues, 35 PCR cycles were performed with denaturation at 948C for 30 s, annealing at 558C for 30 s, extension at 728C for 1 min, and a ®nal extension step at 728C for 7 min. Ampli®cation from human cortex was carried out using a Touchdown-Hot Start PCR protocol. Brie¯y, denaturation and extension conditions were as described above, but the annealing temperature was reduced from 60 to 508C, with three cycles at 60, 57, 54 and 528C and 25 cycles at 508C. PCR products were separated by electrophoresis on 1.5% agarose gels in 1Â TAE or 1Â TBE, stained with ethidium bromide and visualized by UV illumination. Polaroid photographs were taken, scanned and imported into photoshop 5.0 (Adobe, San Jose, CA, USA).
Subcloning and sequencing PCR products were subcloned using PCR-Script Amp cloning kit (Stratagene, La Jolla, CA, USA) and individual clones sequenced using [
35 S]dATP chain termination reaction of Sequenase 2.0 (Amersham, Piscataway, NJ, USA) or sent to the Davis sequencing facility for automated sequencing. Sequence comparison and posttranslational protein analyses were performed using MacVector or web browser-based software (http://www.cbs.tdu.dk).
Ribonuclease protection assay A cloned fragment of the human OFQ/N transcript was further ampli®ed for 15 cycles using primer pairs P3 and P3b. The resulting 456 bp fragment, corresponding to a segment spanning exons 2 and 3 of the human OFQ/N message, was subcloned into pBS SK(±) cloning vector (Stratagene), sequenced, linearized with NotI (Life Technologies), and used as a template for cRNA synthesis using T7 RNA polymerase (Promega) in the presence of [ 32 P]CTP nucleotide (NEN, Boston, MA, USA). Unlabeled sense cRNA was synthesized with T3 RNA polymerase (Promega), using EcoRV-digested clones representing human N23K and N23K (Mollereau et al. 1996) . The translational start site for ppOFQ/N is marked with an arrow, the coding region is denoted with cross-hatching and the putative alternative splice junction is indicated by an asterisk. The PCR primers used to span the putative splice site at the 3 H -end of exon 3 for each species are listed in Table 1 and are marked in bold. The expected lengths of the ampli®ed products are in the dotted boxes. (b) RT-PCR of rat and human brain spanning exons 2±4. Two micrograms of total RNA was reversed transcribed and subjected to PCR using the primer pairs indicated in (a) and the parameters described in Materials and methods. The (±) control represent PCR reactions for rat and human RNA from which the reverse transcriptase was omitted. DNA molecular mass size markers are on the left, whereas the numbers on the right correspond to the size (bp) of the individual PCR products. (c) Comparison of the translated C-termini of the differentially spliced ppOFQ/N transcripts across species. Potential basic processing sites have been underlined, conserved amino acids shaded, and conserved cystein residues boxed.
minus exon 2 ppOFQ/N transcripts. The sense cRNA samples were puri®ed through a Sephadex G50 column and their concentrations assessed spectrophotometrically. Protection assays were conducted using HybSpeed RPA kit (Ambion, Austin, TX, USA) according to the manufacturer's suggested protocols. Samples were electrophoresed in 5% acrylamide gels and exposed overnight to X-OMAT ®lm (Eastman Kodak, Rochester, NY, USA) at 2708C with an intensifying screen. Quantitation of the protected fragments was performed by densitometry analyses (Molecular Dynamics, Sunnyvale, CA, USA).
In vitro transcription and translation
Depending on the orientation of the clones, vectors were linearized using either EcoRV or SacII restriction enzymes (New England Biolabs, Beverly, MA, USA) that cut at unique sites within the multipurpose cloning site. Sense RNA was synthesized from each clone using the appropriate T3 or T7 polymerase (Promega). Following phenol/chloroform extraction and ethanol precipitation, the RNA was translated in vitro with [ 35 S]methionine using Retic Lysate IVT (Ambion). The resulting reactions were electrophoresed along with rainbow molecular mass markers (Amersham) on a 15% polyacrylamide gel, ®xed with 10% acetic acid and 45% methanol, dried and exposed using a phosphoimager screen (Kodak/Molecular Dynamics).
Results
Alternative splicing of ppOFQ/N transcripts within exon 3 in rat and human brain The gene structures of the rat and human ppOFQ/N and the location of the PCR primers used in this study are depicted in Fig. 1 (a) . RT-PCR analysis of rat and human brain RNA using primers spanning exons 2±4 yielded the expected length fragment of 644 and 767 bp, respectively. In addition, a shorter band from both species was also ampli®ed (Fig. 1b) . Sequence analysis of all the ampli®ed fragments revealed that the shorter bands corresponded to a ppOFQ/N message from which the 3 H -terminal region of exon 3 is omitted. The use of such an alternative donor splice site corresponds exactly to the previously described murine N27K splice variant (Saito et al. 1996) . The predicted translated C-terminus for both ppOFQ/N splice variants of the rat and human have been aligned with the mouse sequence in Fig. 1(c) (Saito et al. 1996) . The C-terminal octapeptide following the presumptive processing site (Arg-Arg-Arg) of N23K is identical between rat, mouse and human. In the case of N27K, the 33 amino acid peptide that follows the same potential processing site has < 66% identity between the species examined. Of note, is the conservation of two cysteine residues in all of the extended C-termini examined. In addition, a polymorphism at position 825 of the human sequence (adenine or cytosine) noted previously in the published sequence (Accession no. U48263; Nothacker et al. 1996) was also observed from the sequencing of multiple independent tissue samples.
Tissue distribution of the rat ppOFQ/N N23K and N27K messages RT-PCR analysis was performed in order to analyze the tissue distribution of ppOFQ/N transcripts in the rat. Fragments corresponding in size to both N23K and N27K transcripts were observed following ampli®cation of RNA isolated from brain and testis (Fig. 2a) . Less intense bands ) RNA from the CNS of embryonic to adult stages was reverse transcribed and ampli®ed as described in Materials and methods. E13 to E18, embryonic day 13±18; P1, postnatal day 1; (±), negative control using water in lieu of cDNA. Fig. 1(a) were observed in the spleen, whereas ampli®cation of OFQ/N transcripts was either undetectable or negligible in the heart, liver, lymph nodes, muscle and thymus. Concurrent PCR reactions using actin primers of the same tissue samples yielded a 630-bp product corresponding to the rat b-actin and served as a positive control for the reverse transcription reaction (Fig. 2b) .
Developmental expression of the rat ppOFQ/N N23K and N27K analogs We examined the developmental expression of the rat ppOFQ/N transcripts by RT-PCR. Brain poly(A 1 )-selected mRNA samples representing various time points during development were analyzed using RT-PCR for the presence of transcripts encoding N23K or N27K. Our analysis revealed that both messages were expressed from the earliest time point examined (embryonic day 13) into adulthood (Fig. 2c) . Although the assay was not designed to be quantitative, the ratio of the full-length (N23K) transcript to the splice variant (N27K) appeared relatively consistent at all developmental time points examined, with the N23K band being more prominent.
Additional ppOFQ/N splice variants in the human cortex Using primers P5 and P6, which span exons 1 and 3 of the human ppOFQ message, RT-PCR analysis of human cortex resulted in the ampli®cation of the expected (693 bp) and a shorter (544 bp) fragment (Fig. 3b, lanes 1 and 2) . Sequence analysis of the longer fragment corresponded to the expected ppOFQ/N transcript, whereas analysis of the shorter band revealed the complete excision of exon 2. Further PCR analysis using primer pairs spanning exons 1±4 revealed a total of four fragments (Fig. 3b, lane 3) . Analogous RT-PCR experiments using human fetal brain stem RNA revealed a similar ampli®cation pattern to cortex (data not shown). Sequence analysis revealed that the two longest products, 865 and 807 bp, correspond to the previously described N23K and N27K ppOFQ/N transcripts, whereas the shorter fragments represent the same transcripts lacking exon 2. In order to assess the abundance of these additional transcripts, we conducted ribonuclease protection assays (RPA). Increasing concentrations of human fetal brainstem total RNA or in vitro transcribed sense RNA corresponding to the human N23K and N23K minus exon 2 were hybridized to a cRNA probe partially spanning exons 2±3 (Fig. 3c) . Protected fragments of 457 nucleotides represent transcripts containing exon 2, whereas the shorter protected fragments of 326 nucleotides depict transcripts lacking exon 2. Calculations based on densitometric analyses of the protected fragments in four independent experiments revealed that transcripts lacking exon 2 constituted only 7.1^3% of the signal generated by exon 2-containing bands. The diagram in Fig. 3(d) illustrates the various ppOFQ/N splice variants present in human cortex. Transcripts lacking exon 2 were not detected in mouse CNS in PCR experiments using primers spanning exon 1 to exon 3 (data not shown).
In vitro translation of various human ppOFQ/N transcripts Examination of the human splice variants missing exon 2 indicates that Met65, located in exon 3, is in-frame with the OFQ/N peptide and encoded within a favorable Kozac consensus sequence (Fig. 4a) . Computer-based analysis of the human N23K ppOFQ/N reveals that the ®rst 19 amino acid residues are highly hydrophobic and represent a candidate signal peptide sequence, whereas the N23K minus exon 2 ppOFQ/N results in a hydrophilic N-terminal, characteristic of cytosolic proteins (Fig. 4b) . Furthermore, the minus exon 2 translation products do not have any stretches of hydrophobic residues that could serve as potential signal peptides. In vitro translation of the human N23K and N27K cRNA transcripts resulted in the translation of proteins migrating at an estimated molecular mass of 24 and 28.5 kDa, respectively (Fig. 4d, lanes 1 and 2) . Translation of the N23K and N27K splice variants lacking exon 2 clones resulted in proteins of < 16.5 and 20 kDa, respectively (Fig. 4d, lanes 3 and 4) .
Discussion
Previous studies of the mouse ppOFQ/N transcripts revealed alternative splicing at the 3 H -end of exon 3 yielding two precursor proteins with different C-terminal sequences (Saito et al. 1996) . The longer transcript, named N23K, corresponds to the cDNA clones isolated during the search for the endogenous NOP receptor ligand (Meunier et al. 1995; Reinscheid et al. 1995) , and gives rise to a predicted precursor protein of 23 kDa containing a short C-terminus following OFQ2 (Fig. 1c) . In the shorter transcript, named N27K, the stop codon in the ORF of exon 3 is removed, resulting in a longer predicted precursor protein with an extended C-terminal sequence.
Here, we report that the pattern of ppOFQ/N transcript splicing originally observed in the mouse is conserved in rat and human tissues (Fig. 1b) and that the predicted translation products of the shorter messages analogous to mouse N27K, also result in extended C-termini. Furthermore, there is a high degree of conservation at the C-terminus of the mouse, rat and human precursors in the predicted protein sequence from both transcripts (Fig. 1c) . Following the dibasic amino acids of OFQ/N, the C-terminal of ppOFQ/N encodes the presumed peptide OFQ2, which is followed by three arginine residues and a varying carboxy tail depending on the splicing pattern of the ppOFQ/N message. Whether OFQ2 is cleaved in vivo at the triple arginines is not known, because the 17 amino acid peptide corresponding to the isolation of the predicted OFQ2 peptide have not yet been reported. If cleavage at this site does not occur, OFQ2 would exist in vivo as a 28 amino acid peptide from N23K and a 53 amino acid peptide from N27K. Alternatively, if there is cleavage at the triple arginine residues, a C-terminal octapeptide would be released from N23K and a 33 amino acid peptide from N27K. The C-terminal octapeptide sequence of N23K is 100% conserved, whereas the 33 amino acids at the C-terminus of N27K are < 66% identical across the species examined (Fig. 1c) . As reported previously, the human sequence is polymorphic at residue 825 and was assumed to encode the 3 H -UTR of the ppOFQ/N transcript (Fig. 4a) (Nothacker et al. 1996) . In our study, polymorphism was con®rmed by sequencing clones form several distinct donors and was mapped to the coding region of the extended C-terminal of the N27K splice variant. Polymorphism (adenine or cytosine) would alter the translation of the extended precursor protein to either a leucine or proline. Interestingly, this amino acid is the only highly divergent region of the extended N27K C-termini in the species examined and is located between two conserved cysteine residues (Fig. 1c) . These conserved cysteine residues could potentially form disul®de bridges. Further analyses of the endogenous ppOFQ/N derived proteins are required to identify the exact nature of the peptides excised from the C-terminus of both the N23K and N27K.
Studies conducted by Saito et al. (1997) reported that murine ppOFQ/N splice variants were expressed during neuronal differentiation and that both transcript and protein levels diminished with maturation. Figure 2 (c) demonstrates that both ppOFQ/N splice variants were present as early as embryonic day 13 in the rat brain and that the expression persisted into adulthood. In addition, it appears that the shorter transcript, corresponding to N27K, was consistently less abundant than the longer N23K transcript, at each time point examined. The differences observed may be attributed to the more sensitive RT-PCR method that we employed for the detection of OFQ/N gene products, as opposed to northern and western blots used by Saito et al. (1997) . Given that the RT-PCR technique used here was not quantitative, it is not possible to assess whether the transcript levels varied over the course of rat brain development; however, the observed relative ratios of the two transcripts at each time point persisted even with fewer ampli®cation cycles (data not shown).
Transcripts encoding OFQ/N have been identi®ed in certain peripheral tissues using northern blots (Mollereau et al. 1996; Nothacker et al. 1996) . Because this technique can not adequately resolve the differences in size between the alternative splice variants, we examined peripheral distribution of the transcripts using RT-PCR. In the rat tissues examined, we noted expression of both transcripts in the testis and minor expression in the spleen and kidney (Fig. 2a) . The low expression of ppOFQ/N transcripts in the spleen and kidney tissues may be due to sympathetic innervation of these tissues, as it has been demonstrated that peripheral nerves express ppOFQ/N transcripts (Kummer and Fischer 1997) . It is noteworthy that OFQ/N RNA expression in rat or mouse testes was not detected in previous studies (Saito et al. 1995; Mollereau et al. 1996; Nothacker et al. 1996) , although faint expression was detected in rat ovaries (Mollereau et al. 1996) . We attribute these differences to the sensitivity of the assays, as the aforementioned studies were based on northern analyses whereas our approach was PCR based. Interestingly, all classical opioid peptide precursor transcripts (pro-opiomelanocortin, proenkephalin, prodynorphin) have been isolated from testis (Pintar et al. 1984; Kilpatrick and Rosenthal 1986; Douglass et al. 1987) . Because OFQ/N inhibits electrically evoked vas deferens constriction, it is highly probable that some of the ppOFQ/N-derived peptides may mediate re¯exes involved in male sexual behavior (BerzeteiGurske et al. 1996; Calo et al. 1996; Champion et al. 1997; Zhang et al. 1997; Nicholson et al. 1998) . Interestingly, OFQ may also modulate sexual behavior at the central level, given that intracerebroventricular OFQ/N administration to female rats enhances the lordosis quotient in a dose-dependent manner (Sinchak et al. 1997) .
In addition to the conserved alternative splicing at the 3 H -end of exon 3, we isolated two novel human OFQ/N splice variants. RT-PCR experiments demonstrate that all four transcripts are detectable in human cortex (Fig. 3b, lane  3) . Sequence analyses of the ampli®ed fragments revealed that the most prominent and largest ampli®ed fragments correspond to N23K and N27K, respectively, and are followed by two shorter fragments corresponding to transcripts devoid of exon 2.
In order to assess the abundance of the novel OFQ/N splice variants missing exon 2, we performed RPA experiments using human fetal brainstem RNA. Our ®ndings suggest that the OFQ/N transcripts devoid of exon 2 are rare transcripts relative to those of N23K and N27K (Fig. 3c) . Because of tissue scarcity, we did not examine the distribution or abundance of the OFQ/N splice variants in the adult human brain. Thus, we can not be certain whether the pattern of the protected fragments observed with the fetal brainstem RNA is representative of other brain regions and other developmental time points. When we examined the mouse for the occurrence similar OFQ/ N splicing pattern, only transcripts containing exon 2 were ampli®ed (data not shown). Because the rat OFQ/N exon 1 sequence has not yet been isolated, we were unable to perform similar analysis in this species. Further comparison with other species will be necessary to ascertain the species speci®city of OFQ/N splicing pattern described in this study.
Splicing exon 2 from the primary ppOFQ/N transcript would remove the translational start site and the signal peptide sequence (a stretch of hydrophobic residues required for the targeting of proteins to the secretory pathway) from preproOFQ/N transcript alternative splicing 727 the precursor. Sequence analyses of these splice variants reveal that the longest ORF resides in-frame with the OFQ/ N peptide and begins at Met65 of the human ppOFQ/N (Fig. 4a) . This methionine is encoded within a favorable Kozak consensus sequence containing a purine at position 23 and a guanine residue at position 14, relative to the ATG start site (Kozak 1996) . Recently, it has been shown that functional signal peptides can exist in the middle of the sequence of precursor protein (Miyakawa et al. 1999) . However, analysis of the predicted truncated ppOFQ/N precursor stemming from translation at Met65 indicates that these precursors would be devoid of any continuous stretch of hydrophobic amino acids that could serve as an internal signal peptide (Fig. 4c ).
Previous studies have described multiple truncated POMC transcripts expressed in both rat and human extrapituitary tissues which, if translated, would lack a signal peptide (Jeannotte et al. 1987; Lacaze-Masmonteil et al. 1987) . Due to the similarities between the truncated POMC and OFQ/N messages, we were interested in testing whether the OFQ/N Met65 could serve as a translational initiation site. The predicted translation products from N23K minus exon 2 and N27K minus exon 2 are calculated to be 13 and 15.8 kDa, respectively. All four human OFQ/N splice variants could be translated in vitro; however, the molecular masses obtained from the translation products were all several kDa larger than the calculated values. We attribute the curious migration of the translation products to the electrophoretic properties of the ppOFQ/N splice variants, because both murine N23K and N27K proteins were named based on their observed sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS2PAGE) mobility, as opposed to their smaller calculated molecular masses of 20.9 and 23.7 kDa, respectively (Saito et al. 1995 (Saito et al. , 1996 . In summary, we have shown that the pattern of ppOFQ/N mRNA splicing described previously in the mouse is conserved in both rats and humans. The splicing of the 3 H -end of exon 3 results in elongated and`conserved' C-termini of the precursor protein. Furthermore, we have described two additional human OFQ/N splice variants which were devoid of exon 2, and whose expression levels in fetal brain were not abundant relative to the messages encoded by N23K and N27K. Finally, although exon 2 contains the predicted translational start site, these latter splice variants could be translated in vitro from an internal methionine, which is in frame with the OFQ/N peptide. The functional roles of the precursor proteins resulting from these novel splicing events, should they be expressed in vivo, remain to be elucidated.
